drugset
drugset / Trial / NCT02124278

Safety and Tolerability of Single Ascending Doses of PUL-042 Inhalation Solution in Healthy Subjects

NCT02124278 ↗

Phase 1 Completed 42 enrolled Pulmotect, Inc.
RandomizedSingle-groupQuadruple-blindPrevention

Summary

The purpose is to determine if single doses of PUL-042 inhalation solution are safe in healthy subjects.

Timeline

Start
2014-02
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject ODN M362 Unknown 4.25 ug Inhaled
Subject Pam2CSK4 Unknown 2.9 ug Inhaled

Indications

No indication recorded.